Skip to content

Research on the molecular genetic mechanism of Meniere's disease.

Research on the molecular genetic mechanism of Meniere's disease.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100290
Enrollment
Unknown
Registered
2025-04-07
Start date
2025-04-07
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meniere's disease

Interventions

Observation group:None

Sponsors

General Hospital of the Chinese People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age greater than 18 years; Meet the diagnostic criteria for Meniere's disease: 1.2 or 2 episodes of vertigo, each lasting 20 minutes to 12 hours; 2. At least one audiological examination during the course of the disease confirms that the affected ear has low to medium frequency sensorineural hearing loss; 3. Fluctuating hearing loss, tinnitus and/or ear fullness in the affected ear; 4. Exclude vertigo caused by other vestibular disorders.

Exclusion criteria

Exclusion criteria: Benign paroxysmal positional vertigo, vestibular neuritis, labyrinthitis, vestibular paroxysmals, posterior circulation ischemia, intracranial space-occupying lesions and other diseases were identified; identify patients with vertigo caused by neurology-related diseases; Patients with severe diseases of other systems.

Design outcomes

Primary

MeasureTime frame
Genetic test results;

Secondary

MeasureTime frame
Clinical findings;

Countries

China

Contacts

Public ContactWang Hongyang

General Hospital of the Chinese People's Liberation Army

whyx301@foxmail.com+86 183 1108 1809

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026